Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (246)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Imatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Imatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Dasatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Dasatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Nilotinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Nilotinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Bosutinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Bosutinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Ponatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Ponatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Asciminib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Asciminib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Radotinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Radotinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Flumatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Flumatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Olverembatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Olverembatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Vodobatinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Vodobatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Gefitinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Gefitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Erlotinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Erlotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

Imatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Dasatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Nilotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Bosutinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Ponatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Asciminib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Radotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Flumatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Olverembatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Vodobatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Gefitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Erlotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

‹ 1 2 3 … 21 ›

Product Range

Company

Global Network

Products

Imatinib

Dasatinib

Nilotinib

Bosutinib

Ponatinib

Asciminib

Radotinib

Flumatinib

Olverembatinib

Vodobatinib

Gefitinib

Erlotinib

Imatinib

Dasatinib

Nilotinib

Bosutinib

Ponatinib

Asciminib

Radotinib

Flumatinib

Olverembatinib

Vodobatinib

Gefitinib

Erlotinib